Trulieve Cannabis Corp.TRLV
ASignal's systematic analysis rates TRLV as Neutral.
Reflects the latest available analysis · analyzed Sep 28, 2026
The case on TRLV
Bull vs bear, surfaced by ASignal's framework agents from public market data. The precise verdict: ASignal Rank, confidence, and price targets - is in the app.
- Positive free cash flow of $232.04M
- Strong gross margin of 59.47%
- Healthy current ratio (5.94x) and quick ratio (3.71x)
- MACD slightly above signal line indicating neutral-to-bullish momentum
- Price above 20-day and 50-day moving averages
- Negative net margin (-41.55%) and return on equity (-47.65%)
- Declining year-over-year revenue growth (-10.30%)
- High beta (1.76x) indicating elevated volatility risk
- Forward P/E of 22.05x may be stretched given negative earnings trend
- MACD histogram slightly negative, suggesting weakening momentum
See the full verdict on TRLV
ASignal Rank (1-4), confidence score, Buffett / Ackman / Dalio grades, price targets, and the full reasoning behind the call.
How ASignal analyzes TRLV
Most investors never get a second opinion, let alone several. ASignal runs TRLV past a panel of specialized investor-framework agents, each calibrated on a distinct school of investing: Warren Buffett's value discipline, Bill Ackman's activist lens, and Ray Dalio's macro view. They don't just score in isolation, they argue: a dedicated Challenger agent pushes back on every conclusion until the panel settles on a reasoned consensus, weighing fundamentals, macro conditions, market sentiment, and price action together. The kind of cross-examined read that takes a research desk hours, ASignal delivers in under two minutes, refreshed every cycle.
The signal direction and the bull and bear case above are free. The precise read, ASignal Rank, framework grades, price targets, and full reasoning, stays with subscribers.